Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
BIOLOGICAL SCIENCES technology Request PS Eurostars: Swedish biotechnology company seeks European SME specialized in (10 SE 67CH 3HWC) developing drugs for cancer and/or autoimmune diseases. Abstract A Swedish SME, intending to submit a Eurostars proposal, is inviting a European SME as partner in a project to develop new methods for detection of cancer/autoimmune diseases. The company has developed a cost effective method for measuring abnormal cell division through a simple blood test, which is used for detection of tumors. The aim of the project is to integrate this technology with technology from the partner. The partner should be an SME developing drugs for cancer/autoimmune diseases. Description One of the most fundamental characteristics of cancer is uncontrolled cell division in the body. By measuring the rate of cell division, one can determine the aggressiveness, spread and growth of the tumor. A Swedish biotechnology SME has developed a cost effective method for measuring abnormal cell division through a simple blood test. This method can be used for detection and disease investigation, as well as therapy monitoring. It is a high sensitivity test allowing the physician to detect ten times smaller growth activity, widens the applicability to solid tumors and prognostic use. The test is complementary to traditional tumor markers. The aim of the Swedish SME is for the cell division test to become a standard procedure in cancer disease investigation and follow-up. To finance the market application and access, a Eurostars application is planned for the autumn 2010. A European SME, active in the area of diagnosis and/or treatment of cancer and/or autoimmune disease, is invited to become a project partner. The aim of the project is to find new methods for detection and monitoring of autoimmune disease and/or of cancer, both which causes abnormal cell proliferation. This should be helpful to tailor treatment strategies to individual patients. It could also open up new ways for inexpensive diagnosis. If the research is successful, the already developed blood test for rate of cell division can be integrated with the technology available from the partner. Technical Specifications / Specific technical requirements of the request Call information: - Eurostars - Deadline: 30 September 2010 Project proposal development stage: - Proposal stage, not yet submitted. Seeking a required second project partner. Total EU funding requested for the project (approximately): - To be determined before project submission. EU funding foreseen for the partner: - To be determined before project submission. It will depend on the tasks realized by the partner. Percentage of EU funding compared to total budget (%): - Depending on country, around 50% for SMEs. Type and role of the required partner: The potential partner is preferably a European SME active in the area of diagnosis and/or treatment of cancer and/or autoimmune disease. The project partner should play an active role in developing and integrating the already developed blood test for rate of cell division with the products and technology available from the partner. 1 BIOLOGICAL SCIENCES technology Request PS Eurostars: Swedish biotechnology company seeks European SME specialized in (10 SE 67CH 3HWC) developing drugs for cancer and/or autoimmune diseases. Valid until: 24/09/2010 For further information (including IPR status) please contact: EDA ÇIG Phone: +(90 212) 292 21 57/311 Fax: +(90 212) 249 50 07 Email: [email protected] 2